Cefpiramide

Cefpiramide (CAS No.: 70797-11-4) is a semisynthetic third generation cephalosporin research compound in the beta lactam antibacterial class, broadly categorized as a small molecule tool for microbiology, antimicrobial resistance, and anti infective drug discovery studies, with reported broad spectrum activity against Gram positive and Gram negative bacterial species including organisms commonly used to model pseudomonal susceptibility, and with biological function linked to inhibition of bacterial cell wall peptidoglycan biosynthesis through interaction with penicillin binding proteins, leading to impaired transpeptidation and loss of cell wall integrity in susceptible strains; consistent with its class profile, activity readouts in vitro are generally assessed by minimum inhibitory concentration methods and are often described across susceptible panels in the low microgram per milliliter to higher microgram per milliliter interval depending on species, inoculum, and beta lactamase background, while mechanistic profiling frequently includes evaluation of beta lactamase sensitivity that is commonly characterized as moderate for this scaffold, and because target resolved biochemical constants are not uniformly reported for all strains, potency interpretation is typically contextualized through comparative microbiology datasets rather than single value endpoint parameters; in biomedical research workflows, cefpiramide is commonly applied in bacterial growth inhibition assays, resistance selection experiments, combination testing with beta lactamase inhibitors or other antibacterial classes, and translational pharmacology studies in infection related cell based or animal research systems, where the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.